PAG
BSX icon

Private Advisor Group’s Boston Scientific BSX Stock Holding History

Private Advisor Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.54M Sell
40,440
-113
-0.3% -$9.04K 0.01% 941
2025
Q4 		$3.87M Buy
40,553
+199
+0.5% +$19.5K 0.02% 736
2025
Q3 		$3.94M Sell
40,354
-360
-0.9% -$37.3K 0.02% 716
2025
Q2 		$4.37M Buy
40,714
+2,440
+6% +$247K 0.02% 621
2025
Q1 		$3.86M Buy
38,274
+3,734
+11% +$376K 0.02% 622
2024
Q4 		$3.09M Sell
34,540
-1,463
-4% -$129K 0.02% 699
2024
Q3 		$3.02M Buy
36,003
+944
+3% +$74.4K 0.02% 711
2024
Q2 		$2.7M Buy
35,059
+3,143
+10% +$230K 0.02% 721
2024
Q1 		$2.19M Buy
31,916
+5,181
+19% +$333K 0.02% 763
2023
Q4 		$1.55M Buy
26,735
+572
+2% +$30.5K 0.01% 889
2023
Q3 		$1.38M Buy
26,163
+1,107
+4% +$58.1K 0.01% 876
2023
Q2 		$1.34M Buy
25,056
+9,908
+65% +$517K 0.01% 904
2023
Q1 		$758K Sell
15,148
-1,109
-7% -$52.3K 0.01% 1129
2022
Q4 		$752 Sell
16,257
-686
-4% -$29.7K ﹤0.01% 1302
2022
Q3 		$656K Sell
16,943
-223,644
-93% -$8.97M 0.01% 1113
2022
Q2 		$8.97M Sell
240,587
-38,104
-14% -$1.55M 0.08% 242
2022
Q1 		$12.3M Buy
278,691
+12,153
+5% +$527K 0.09% 206
2021
Q4 		$11.3M Sell
266,538
-73,317
-22% -$3.08M 0.08% 232
2021
Q3 		$14.7M Buy
339,855
+159,448
+88% +$7.05M 0.09% 218
2021
Q2 		$7.71M Buy
180,407
+13,229
+8% +$557K 0.07% 288
2021
Q1 		$6.46M Buy
167,178
+38,319
+30% +$1.45M 0.06% 314
2020
Q4 		$4.63M Buy
128,859
+104,600
+431% +$3.77M 0.05% 348
2020
Q3 		$897K Buy
24,259
+731
+3% +$28.2K 0.01% 826
2020
Q2 		$826K Sell
23,528
-659
-3% -$23.7K 0.01% 840
2020
Q1 		$789K Sell
24,187
-4,242
-15% -$166K 0.01% 737
2019
Q4 		$1.29M Sell
28,429
-12,115
-30% -$507K 0.02% 676
2019
Q3 		$1.66M Buy
40,544
+7,921
+24% +$336K 0.03% 602
2019
Q2 		$1.4M Buy
32,623
+9,669
+42% +$372K 0.03% 597
2019
Q1 		$881K Buy
22,954
+6,506
+40% +$248K 0.02% 724
2018
Q4 		$582K Sell
16,448
-7,081
-30% -$257K 0.01% 794
2018
Q3 		$906K Sell
23,529
-29,626
-56% -$1.03M 0.02% 729
2018
Q2 		$1.74M Buy
+53,155
New +$1.6M 0.03% 322
2018
Q1 		– Sell
-20,759
Closed -$534K – 1183
2017
Q4 		$534K Buy
20,759
+1,896
+10% +$52.3K 0.02% 636
2017
Q3 		$553K Sell
18,863
-513
-3% -$14.2K 0.01% 855
2017
Q2 		$534K Buy
19,376
+4,069
+27% +$108K 0.01% 805
2017
Q1 		$384K Sell
15,307
-3,443
-18% -$83.7K 0.01% 958
2016
Q4 		$437K Buy
18,750
+9,443
+101% +$206K 0.01% 785
2016
Q3 		$217K Sell
9,307
-4,678
-33% -$112K 0.01% 981
2016
Q2 		$331K Buy
+13,985
New +$303K 0.01% 776
2016
Q1 		– Sell
-11,656
Closed -$215K – 1042
2015
Q4 		$215K Buy
11,656
+749
+7% +$13.4K 0.01% 923
2015
Q3 		$179K Buy
10,907
+116
+1% +$1.98K 0.01% 909
2015
Q2 		$191K Buy
10,791
+388
+4% +$6.93K 0.01% 951
2015
Q1 		$185K Sell
10,403
-1,394
-12% -$22K 0.01% 903
2014
Q4 		$156K Sell
11,797
-1,969
-14% -$25.2K 0.01% 898
2014
Q3 		$163K Sell
13,766
-18,428
-57% -$232K 0.01% 887
2014
Q2 		$411K Buy
32,194
+16,255
+102% +$211K 0.04% 555
2014
Q1 		$215K Buy
15,939
+2,750
+21% +$36.1K 0.02% 680
2013
Q4 		$159K Buy
+13,189
New +$156K 0.02% 687

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Private Advisor Group's BSX Position: Q1 2026 in Review

Private Advisor Group reduced its Boston Scientific (BSX) stake by 0.28% in Q1 2026, selling an estimated $9.04K and leaving 40,440 shares worth $2.54M. The position accounts for 0.01% of the portfolio, ranked #941.

Private Advisor Group first reported a position in BSX in Q4 2013 and has held it in 48 quarters since. The position peaked at $14.7M in Q3 2021. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Private Advisor Group held 40,440 shares of Boston Scientific worth $2.54M as of Q1 2026.
  • Private Advisor Group sold 113 Boston Scientific shares in Q1 2026, an estimated $9.04K.
  • Boston Scientific made up 0.01% of Private Advisor Group's portfolio in Q1 2026, its #941 holding.
  • Private Advisor Group first reported a position in Boston Scientific in Q4 2013 and has held it in 48 quarters since.
  • Private Advisor Group's Boston Scientific position peaked at $14.7M in Q3 2021.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.